Panel Discussion: Understanding Large Pharma’s Thought-Process on Establishing Partnerships With Innovative Biotech to Inform Your Development Strategy

• Understanding the pharma priorities when it comes to licensing and partnerships
• Discussing strategies for collaborating that align with scientific and business opportunities
• Identifying the best path for collaborations to ensure successful alliances

Speakers:

John Flygare

Head of Large Molecule & ADC Innovation

Eli Lilly

Kaisheng Huang

Chief Operating Officer & Chief Quality Officer

Remegen

Koji Yashiro

Director

MSD

Matthew Levengood

Director

Pfizer